Brief Reports
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 292-294
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.292
Table 1 COX-2 expression in gastric cancer and paracancerous tissues
NumberCOX-2 expression intensityb
Positive
-++++++ratedn (%)
Gastric cancer301048820 (66.7)
Paracancerous tissue30226208 (26.7)
Table 2 COX-2 expression in gastric mucosa with H pylori infection, n (%)
CG (n = 30)
IM (n = 19)
DYS (n = 11)
GC (n = 30)
Hp+Hp -Hp+Hp -Hp +Hp -Hp +Hp -
n255911561119
COX-22 (8.0%)1 (0%)5 (50.6%)a2 (18.1%)3 (60.0%)a2 (33.3%)8 (72.7%)12 (63.5%)
Table 3 COX-2 expression in gastric cancer tissues
GroupsNumberCOX-2 n (%)
Type
Intestinal type2416 (66.7)
Gastric type64 (66.7)
Stage
Early stage51 (20.0)
Developing2519 (76.0)a
Differentiation (Intestinal type)
High and moderate148 (57.1)
Low and no differentiation108 (80.0)
Lymph node metastasis
Without metastasis61 (16.7)
With metastasis2419 (79.2)a